Biofocus will perform screening on behalf of its customers using Discoverx Pathhunter Beta-Arrestin GPCR screening assay, Hithunter, CAMP assays and associated cell lines.
This is the result of Biofocus and Discoverx signing a co-marketing agreement.
Discoverx has a portfolio of non-force coupled GPCR cell lines utilising its Pathhunter Beta-Arrestin GPCR platform as well as Hithunter CAMP detection.
These validated cell lines and associated detection platform have been used in numerous drug discovery campaigns for de-orphanisation and identifying novel hits.
